Holmgren et al. report the long-term outcome of aortic valve replacement patients for bicuspid or tricuspid aortic valve pathologies within a Swedish cohort. In their analysis, patients with bicuspid valve morphology showed an independent association with improved outcome, even matching the general population´s prognosis.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
Long-Term Results After Aortic Valve Replacement for Bicuspid or Tricuspid Valve Morphology in a Swedish Population
March 25, 2021
March 9, 2021
In this CTSNet To Go podcast episode, Jessica Luc interviews Marc Ruel about his pioneering work in minimally invasive cardiac surgical operations.
The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies
February 21, 2021
In this article, Thourani et al present the International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on transcatheter and surgical aortic valve replacement in low- and intermediate-risk patients: A meta-analysis of randomized and propensity-matched studies.
Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren: A Cluster Randomized Clinical Trial
February 4, 2021
Rheumatic heart disease (RHD) continues to be responsible for major cardiovascular morbidity and mortality in the developing world. It constitutes a double tragedy because it disproportionately affects economically disadvantaged people and young people, thereby robbing them of the most productive years of life.
Case Report: Repair of Type A Aortic Dissection After TAVR With an Uncovered Thoracic Endograft Without General Anesthesia
January 19, 2021
This is a case report of the repair of a type A aortic dissection after TAVR with an uncovered thoracic endograft.
January 8, 2021
Froede et al. present a new simplified technique to determine commissural orientation in bicuspid aortic valves using echocardiography. Their technique using a line between the center of the nonfused and fused sinuses led to reproducible results, whereas the use of the coaptation center led to misleading results.
Two Decades of Valve-Sparing Root Reimplantation in Tricuspid Aortic Valve: Impact of Aortic Regurgitation and Cusp Repair
December 22, 2020
Tamer et al. analyzed the influence of preoperative aortic regurgitation (AR) on the necessity of cusp repair during valve-sparing reimplantation (VSR). They focused on patients with tricuspid aortic valves (TAV) and evaluated the impact of AR and cusp repair on long-term outcomes.
Mortality in Low-Risk Patients With Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement: A Reconstructed Individual Patient Data Meta-Analysis
December 18, 2020
Celik et al. present a meta-analysis regarding the outcome of TAVI implantation with respect to the survival six years after the implantation and compared it to the outcome of surgical aortic valve replacement.
Reoperative Valve-Sparing Root Replacement and Pulmonary Homograft Reconstruction of RVOT Following Pediatric Ross Procedure
November 9, 2020
Valve-sparing root replacement with neo-aortic valve repair is feasible in patients presenting with late aneurysmal growth and dilatation of the neo-aortic root following a pediatric Ross procedure, even in the presence of concomitant valvular disease requiring replacement or reconstruction.
#4: CTSNet Beat Podcast: EXCEL and the European Guidelines, Percutaneous Interventions With Coronary Bypass, Aortic Emergency During COVID-19, and Osimertinib in Positive Resected Cancer
November 4, 2020
In this Beat podcast episode, Joel Dunning discusses the EXCEL trial and European guidelines, percutaneous interventions with coronary bypass surgery, management of aortic emergencies during COVID-19, and osimertinib in positive resected cancer.